HomeNewsBusinessEarningsDr Reddy's Labs expects stronger growth from US market

Dr Reddy's Labs expects stronger growth from US market

Reacting on the numbers in the press conference, company's vice chairman and CEO GV Prasad said that it was a good quarter in terms of growth; the company grew by 18%, reports CNBC-TV18’s Ekta Batra.

July 20, 2011 / 18:41 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Dr Reddy's Labs has reported a 21.5% fall in its first quarter FY12 net profit to Rs 263 crore against Rs 335 crore in the year ago period, as per IFRS. Net sales too declined nearly 2% to Rs 1,978 crore from Rs 2,017 crore year-on-year. Its bottomline was way below expectations while topline was in-line. Its EBITDA margin grew by 14%, lower as compared to 15.6% growth in same quarter the previous year.

Also read: Dr Reddy's Labs Q1 net profit down 21.5% at Rs 263 crore Reacting on the numbers in the press conference, company
first published: Jul 20, 2011 06:02 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!